SIAMAB THERAPEUTICS

Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Diagnostic kits consisting of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Laboratory chemicals, namely, antibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use

Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, monoclonal antibodies for treating cancer, immune disorders, inflammation, neoplasms, rare diseases, genetic diseases, inborn error of metabolism and auto-immune diseases

Scientific research; scientific research in the fields of biochemicals, namely, monoclonal antibodies; scientific research in the fields of diagnostic kits, consisting of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; scientific research in the field of laboratory chemicals, namely, antibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use